<DOC>
	<DOCNO>NCT01199016</DOCNO>
	<brief_summary>Prevnar ( 7 valent pneumococcal conjugate vaccine [ 7vPnC ] ) show effective ear infection child . Prevnar 13 new vaccine similar Prevnar . It expect effectiveness Prevnar 13 ear infection child similar observe following Prevnar . Pfizer committed conduct postmarketing study impact Prevnar 13 reduce ear infection among child .</brief_summary>
	<brief_title>Effect Prevnar 13 Ear Infections Children</brief_title>
	<detailed_description>Infants complete Prevnar 13 infant vaccination series provide consent fit study inclusion criterion participate study recruit .</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Subject receive full ( 3dose ) infant series Prevnar 13 Prior vaccination 7vPnC . Prior vaccination 23valent pneumococcal polysaccharide vaccine ( 23vPS ) . Any major illness/condition , investigator 's judgment , substantially increase risk associate subject 's participation study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>30 Months</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Acute otitis medium</keyword>
	<keyword>Prevnar 13</keyword>
	<keyword>Streptococcus pneumoniae</keyword>
	<keyword>nasopharyngeal colonization .</keyword>
</DOC>